Skip to content
Disclosery

Capital Research Global Investors: GSK position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Capital Research Global Investors on GSK, newest first. How the timeline and the estimate are built.

Capital Research Global Investors held 0 GSK shares at 2025-12-31 per its 13F-HR filed 2026-02-11.

the latest 13F is the newest step

  1. period ended2025-12-31
    13F 0 shares
    Change vs previous 13F -1,794,427 shares

    13F-HR 0001422848-26-000005 filed by Capital Research Global Investors
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  2. period ended2025-09-30
    13F 1,794,427 shares
    Change vs previous 13F +17,615 shares

    0.01% of the 13F portfolio, value $77,447,469.

    13F-HR 0001422848-25-000223 filed by Capital Research Global Investors
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-06-30
    13F 1,776,812 shares
    Change vs previous 13F +14,654 shares

    0.01% of the 13F portfolio, value $68,229,581.

    13F-HR 0001422848-25-000149 filed by Capital Research Global Investors
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-03-31
    13F 1,762,158 shares
    Change vs previous 13F +2,950 shares

    0.01% of the 13F portfolio, value $68,266,001.

    13F-HR 0000732812-25-000014 filed by Capital Research Global Investors
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2024-12-31
    13F 1,759,208 shares
    Change vs previous 13F +4,715 shares

    0.01% of the 13F portfolio, value $59,496,415.

    13F-HR 0001422848-25-000010 filed by Capital Research Global Investors
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2024-09-30
    13F 1,754,493 shares
    Change vs previous 13F not available

    0.01% of the 13F portfolio, value $71,723,674.

    13F-HR 0000017283-24-000030 filed by Capital Research Global Investors
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).